BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9350074)

  • 1. Minimal residual disease in B-lymphoproliferative disorders by PCR detection of immunoglobulin heavy chain gene recombination.
    Petroni D; Saglio G
    Scand J Clin Lab Invest; 1997 Oct; 57(6):541-7. PubMed ID: 9350074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of immunoglobulin gene rearrangement in lymphoid malignancies of B-cell lineage by seminested polymerase chain reaction gene amplification.
    Liang R; Chan V; Chan TK; Wong T; Chiu E; Lie A; Todd D
    Am J Hematol; 1993 May; 43(1):24-8. PubMed ID: 8317459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antigen receptor gene rearrangements in lymphoproliferative malignancies by fluorescent polymerase chain reaction.
    Kerlan-Candon S; Soua Z; Lefranc MP; Clot J; Eliaou JF
    Tissue Antigens; 1998 Jan; 51(1):20-9. PubMed ID: 9459500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of immunoglobulin heavy chain variable gene repertoires and highly selective detection of malignant clonotypes in acute lymphoblastic leukemia.
    Greenberg SJ; Choi Y; Ballow M; Du TL; Ward PM; Rickert MH; Frankel S; Bernstein SH; Brecher ML
    J Leukoc Biol; 1995 Jun; 57(6):856-64. PubMed ID: 7790768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia.
    Donovan JW; Ladetto M; Zou G; Neuberg D; Poor C; Bowers D; Gribben JG
    Blood; 2000 Apr; 95(8):2651-8. PubMed ID: 10753847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes.
    Jonsson OG; Kitchens RL; Scott FC; Smith RG
    Blood; 1990 Nov; 76(10):2072-9. PubMed ID: 2122920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable rate of detection of immunoglobulin heavy chain V-D-J rearrangement by PCR: a systematic study of 41 B-cell non-Hodgkin's lymphomas and leukemias.
    Ben-Ezra J
    Leuk Lymphoma; 1992 Jul; 7(4):289-95. PubMed ID: 1493428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of immunoglobulin heavy chain variable genes in B-chronic lymphocytic leukemia.
    Bertin P; Risueño C; Meller C
    Ann N Y Acad Sci; 1995 Sep; 764():474-7. PubMed ID: 7486569
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
    Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
    Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular detection and characterization of clonal cell populations in acute lymphocytic leukemia by analysis of conformational polymorphisms of cRNA molecules of rearranged T-cell-receptor-gamma and immunoglobulin heavy-chain genes.
    Koch OM; Volkenandt M; Göker E; Buer J; Probst M; Banerjee D; Danenberg PV; Bertino JR
    Leukemia; 1994 Jun; 8(6):946-52. PubMed ID: 8207989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias.
    Deane M; Norton JD
    Eur J Immunol; 1990 Oct; 20(10):2209-17. PubMed ID: 1700749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal residual disease detection in B-cell malignancies by assessing IgH rearrangement.
    Maloum K; Pritsch O; Dighiero G
    Hematol Cell Ther; 1997 Jun; 39(3):119-24. PubMed ID: 9262987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction.
    Arons E; Margulies I; Sorbara L; Raffeld M; Stetler-Stevenson M; Pastan I; Kreitman RJ
    Clin Cancer Res; 2006 May; 12(9):2804-11. PubMed ID: 16675574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size and frequency of the DNA fragments in the rearranged immunoglobulin heavy chain joining regions in the lymphocytic leukemias.
    Stolc V; Uhrmacher J; Krause JR
    Anticancer Res; 1991; 11(2):813-6. PubMed ID: 1905906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
    Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
    N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of minimal residual disease in B-lymphoproliferative disorders: a three step SSCP-PCR method.
    Miglino M; Grasso R; Pietrasanta D; Palmisano GL; Berisso G; Clavio M; Pierri I; Santini G; Canepa L; Gobbi M
    J Exp Clin Cancer Res; 2001 Mar; 20(1):95-101. PubMed ID: 11370837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.
    Ritgen M; Stilgenbauer S; von Neuhoff N; Humpe A; Brüggemann M; Pott C; Raff T; Kröber A; Bunjes D; Schlenk R; Schmitz N; Döhner H; Kneba M; Dreger P
    Blood; 2004 Oct; 104(8):2600-2. PubMed ID: 15205268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical perspective on immunoglobulin heavy chain clonal heterogeneity in B cell acute lymphoblastic leukemia.
    Fries C; Burack WR
    Leuk Res; 2018 Dec; 75():15-22. PubMed ID: 30445235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and structural analysis of rearranged immunoglobulin heavy chain genes in lymphomas and leukemias.
    Linke B; Pyttlich J; Tiemann M; Suttorp M; Parwaresch R; Hiddemann W; Kneba M
    Leukemia; 1995 May; 9(5):840-7. PubMed ID: 7769847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.